pmid: 31760822,   nlmid 101150203,  doi:10.1080/14756366.2019.1689237

Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease.


Fancellu, Gaia Chand, Karam Tomás, Daniel Orlandini, Elisabetta Piemontese, Luca Silva, Diana F Cardoso, Sandra M Chaves, Sílvia Santos, M Amélia

Vol. 35, Issue 35, Dec.2020

Journal of enzyme inhibition and medicinal chemistry (J Enzyme Inhib Med Chem),  ISSN 1475-6374

Abstract

Pursuing the widespread interest on multi-target drugs to combat Alzheimer´s disease (AD), a new series of hybrids was designed and developed based on the repositioning of the well-known acetylcholinesterase (AChE) inhibitor, tacrine (TAC), by its coupling to benzofuran (BF) derivatives. The BF framework aims to endow the conjugate molecules with ability for inhibition of AChE (bimodal way) and of amyloid-beta peptide aggregation, besides providing metal (Fe, Cu) chelating ability and concomitant extra anti-oxidant activity, for the hybrids with hydroxyl substitution. The new TAC-BF conjugates showed very good activity for AChE inhibition (sub-micromolar range) and good capacity for the inhibition of self- and Cu-mediated A? aggregation, with dependence on the linker size and substituent groups of each main moiety. Neuroprotective effects were also found for the compounds through viability assays of neuroblastoma cells, after A? induced toxicity. Structure-activity relationship analysis provides insights on the best structural parameters, to take in consideration for future studies in view of potential applications in AD therapy.


MESH Headings

Acetylcholinesterase | Alzheimer Disease | Animals | Benzofurans | Cholinesterase Inhibitors | Dose-Response Relationship, Drug | Electrophorus | Humans | Models, Molecular | Molecular Structure | Neuroprotective Agents | Structure-Activity Relationship | Tacrine | metabolism | drug therapy | metabolism | chemistry | pharmacology | chemical synthesis | chemistry | pharmacology | chemical synthesis | chemistry | pharmacology | chemistry | pharmacology |


Article Keywords

AChE inhibitors | Alzheimer?s disease | metal chelators | multi-target drugs | tacrine-benzofuran hybrids |


Chemical

Benzofurans | Cholinesterase Inhibitors | Neuroprotective Agents | Tacrine | Acetylcholinesterase | benzofuran |

Similar Articles

Multifunctional novel Diallyl disulfide (DADS) derivatives with ?-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
Manral, Apra Saini, Vikas Meena, Poonam Tiwari, Manisha
Bioorganic & medicinal chemistry ,vol(23), issue(19),  Oct.2015

Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
Camps, Pelayo Formosa, Xavier Galdeano, Carles Gómez, Tŕnia Muńoz-Torrero, Diego Ramírez, Lorena Viayna, Elisabet Gómez, Elena Isambert, Nicolás Lavilla, Rodolfo Badia, Albert Clos, M Victňria Bartolini, Manuela Mancini, Francesca Andrisano, Vincenza Bidon-Chanal, Axel Huertas, Oscar Dafni, Thomai Luque, F Javier
Chemico-biological interactions ,vol(187), issue(1-3),  Sep.2010

Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A? aggregation, and ?-secretase.
Sun, Qi Peng, Da-Yong Yang, Sheng-Gang Zhu, Xiao-Lei Yang, Wen-Chao Yang, Guang-Fu
Bioorganic & medicinal chemistry ,vol(22), issue(17),  Sep.2014

Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
Luo, Wen Li, Yan-Ping He, Yan Huang, Shi-Liang Li, Ding Gu, Lian-Quan Huang, Zhi-Shu
European journal of medicinal chemistry ,vol(46), issue(6),  Jun.2011

Multifunctional iron-chelators with protective roles against neurodegenerative diseases.
Nunes, Andreia Marques, Sérgio M Quintanova, Catarina Silva, Diana F Cardoso, Sandra M Chaves, Sílvia Santos, M Amélia
Dalton transactions (Cambridge, England : 2003) ,vol(42), issue(17),  May.2013

Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer, E Sadeghpour, H Nadri, H Sakhteman, A Tüylü Küçükk?l?nç, T Miri, R Edraki, N
Bioorganic chemistry ,vol(89), issue(),  Aug.2019

Clicked tacrine conjugates as acetylcholinesterase and ?-amyloid directed compounds.
Ouberai, Myriam Brannstrom, Kristoffer Vestling, Monika Olofsson, Anders Dumy, Pascal Chierici, Sabine Garcia, Julian
Organic & biomolecular chemistry ,vol(9), issue(4),  Feb.2011

A review on cholinesterase inhibitors for Alzheimer's disease.
Anand, Preet Singh, Baldev
Archives of pharmacal research ,vol(36), issue(4),  Apr.2013

Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri, Rangappa S Quintanova, Catarina Marques, Sérgio M Esteves, A Raquel Cardoso, Sandra M Santos, M Amélia
Bioorganic & medicinal chemistry ,vol(21), issue(15),  Aug.2013

Docking-based design and synthesis of galantamine-camphane hybrids as inhibitors of acetylcholinesterase.
Stavrakov, Georgi Philipova, Irena Zheleva-Dimitrova, Dimitrina Valkova, Iva Salamanova, Evdokiya Konstantinov, Spiro Doytchinova, Irini
Chemical biology & drug design ,vol(90), issue(5),  Nov.2017


Medline data is available here.

The Search Enterprise

Contact Us